Complement-Based Drug Development Summit leaderboard
  • Thursday, September 3, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

17th World ADC San Diego Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 511

Author

Pharma Journalist 9038 posts 0 comments

Jace Blackburn, Smart Device Engineer, Genentech will be presenting at the inaugural Pre-filled…

May 19, 2020
SMi Reports: SMi Group are delighted to announce that Jace Blackburn, Smart Device Engineer, Genentech will be a speaker at the inaugural Pre-filled Syringes San Francisco Conference on…
Read More...

Innovent Biologics and MD Anderson Announce a Strategic Collaboration to Develop anti-PD-1 Therapy…

May 19, 2020
Innovent Biologics, Inc. and The University of Texas MD Anderson Cancer Center announced a strategic collaboration agreement to co-develop TYVYT (sintilimab injection), Innovent's…
Read More...

AstraZeneca gets breakthrough status for Enhertu to treat NSCLC

May 19, 2020
AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo)’s Enhertu (trastuzumab deruxtecan) has been granted Breakthrough Therapy Designation (BTD) in the US for the treatment…
Read More...

Registration is now open for the 2nd annual Wearable Injectors and Connected Devices Conference 2020

May 19, 2020
SMi Reports: Registration is open for SMi Group’s 2nd annual Wearable Injectors and Connected Devices Conference taking place in October. SMi’s 2nd annual Wearable Injectors and…
Read More...

FDA Grants Full Approval of Deciphera Pharmaceuticals’ QINLOCK (ripretinib) for the Treatment of…

May 18, 2020
Deciphera Pharmaceuticals, Inc. announced the U.S. Food and Drug Administration (FDA) has approved QINLOCK (ripretinib) for the treatment of adult patients with advanced…
Read More...

Takeda China announces ADCETRIS (brentuximab vedotin) is approved for the treatment of adult…

May 15, 2020
Takeda China announced that ADCETRIS (brentuximab vedotin) has been officially approved by China’s National Medical Products Administration (NMPA) for use in adult patients with…
Read More...

Boehringer Acquires Northern Biologics’ Preclinical Cancer Antibody Pipeline

May 15, 2020
Boehringer Ingelheim announced the acquisition of Northern Biologics Inc., a wholly owned subsidiary of Northern LP. By acquiring this entity, which focuses on therapeutic antibodies…
Read More...

New date announced for SMi’s Pharmaceutical Microbiology East Coast Conference

May 15, 2020
SMi Reports: New confirmed key speakers and updated agenda for Pharmaceutical Microbiology East Coast, with new dates due to the COVID-19 pandemic, the conference is now taking place on…
Read More...

Hit the JAK-pot in global race to treat COVID-19

May 15, 2020
There is no time like the present to share insights with peers on the new clinical trials being initiated to investigate JAK inhibitor use in patients with COVID-19. This critical…
Read More...

Colorcon Launches SoteriaRx On-Dose Authentication Technology Platform

May 14, 2020
Colorcon, a world leader in the development and supply of film coating systems and excipients, today announces SoteriaRx. This new platform of innovative on-dose technologies and…
Read More...
Prev Next
Microbiome Movement USA Summit 2026
Cell Therapy for Autoimmune Disease Summit
Complement-Based Drug Development Summit
World CNS Summit South Korea
Novel CNS Biomarkers Summit Europe
8th CNS Drug Delivery Summit
Biomarker Operations & Biospecimen Management
2nd Obesity & Weight Loss Drug Development Summit Europe
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
Neuropsychiatric Drug Development Summit
10th IPF Summit
ADC Payload Summit 2026
10th Antifibrotic Drug Development Summit 2026
Model-Informed Drug Development Summit 2026
IMPACCT Real-World Evidence Summit
Raw Materials for Cell & Gene Therapy Summit
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • World ADC Awards 2026 Shortlist Announced, Recognizing Excellence Across the ADC Industry
  • Cipla Licenses HER2 Cancer Drug TQB2102 Across Emerging Markets
  • FDA Approves BESREMi for Essential Thrombocythemia After 30 Years
  • Teva Discusses Lower Medicaid Drug Prices With Trump Administration
  • Kazia Therapeutics Raises $40 Million to Advance Paxalisib Trials

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

World ADC Awards 2026 Shortlist Announced, Recognizing…

2nd T-Cell Engager for Autoimmune Disease Summit to Deliver…

2nd T-Cell Engager for Autoimmune Disease Summit Returns in…

New Era for Autoimmune T-Cell Engagers Takes Centre Stage…

From Innovation to Acquisition: CrossBridge Bio’s ADC…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.